Red Yeast Rice 2400 mg 120 caps
Food supplement declared in France, declaration No 2019-5-382
Red Yeast Rice 2400 mg 120 caps (PROZIS) is a food supplement declared in France. Status: withdrawn from the market on 26 May 2024. Main ingredients: Monascus purpureus 2,400 mg per day. 1 point in its composition requires a check (prohibited substance, dose or novel food). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Withdrawn from the market on 26 May 2024
- Form
- Capsule
- Daily dose
- 4 gélules
- Directions for use
- Prendre 2 gélules au déjeuner et 2 gélules au dîner.
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Pregnant women, Kidney disease, Liver problems, Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Arteries and cholesterol
Declaration 213187, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Monascus purpureus Went | Graine | Poudre (de plantes séchées ou broyées) | 2,400 mg |
Additives
E460, E470b, E551, E171
Other ingredients
gélatine, maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
L'effet bénéfique est obtenu en prenant 10 mg par jour de monacoline K provenant de préparations de riz rouge fermenté. Ce produit ne convient pas aux femmes enceintes et allaitantes, aux enfants, aux adolescents et aux personnes sensibles aux statines (en raison de la présence de monacoline), aux personnes de plus de 70 ans, aux personnes souffrant de maladies du foie,des reins ou des muscles, et aux personnes qui prennent des médicaments hypolipidémiants ou autres, à cause du risque d'interaction. Veuillez consulter un médecin avant d'utiliser ce produit. Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/860).
- Information
Withdrawn from the market on 26 May 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Red Yeast Rice 2400 mg 120 caps (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/213187-red-yeast-rice-2400-mg-120-caps, updated 15 November 2026.